Your browser doesn't support javascript.
loading
Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study.
Herce, Michael E; Morse, Jill; Luhanga, Dora; Harris, Jennifer; Smith, Helene J; Besa, Stable; Samungole, Graham; Kancheya, Nzali; Muyoyeta, Monde; Reid, Stewart E.
Afiliación
  • Herce ME; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia. michael.herce@cidrz.org.
  • Morse J; Division of Infectious Diseases, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. michael.herce@cidrz.org.
  • Luhanga D; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Harris J; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Smith HJ; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Besa S; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
  • Samungole G; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Kancheya N; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
  • Muyoyeta M; Lusaka District Health Office, Ministry of Health, Government of the Republic of Zambia, Lusaka, Zambia.
  • Reid SE; Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
BMC Infect Dis ; 18(1): 536, 2018 Oct 26.
Article en En | MEDLINE | ID: mdl-30367622
ABSTRACT

BACKGROUND:

Patients with HIV-associated tuberculosis (TB) often have their TB and HIV managed in separate vertical programs that offer care for each disease with little coordination. Such "siloed" approaches are associated with diagnostic and treatment delays, which contribute to unnecessary morbidity and mortality. To improve TB/HIV care coordination and early ART initiation, we integrated HIV care and treatment into two busy TB clinics in Zambia. We report here the effects of our intervention on outcomes of linkage to HIV care, early ART uptake, and TB treatment success for patients with HIV-associated TB in Lusaka, Zambia.

METHODS:

We provided integrated HIV treatment and care using a "one-stop shop" model intervention. All new or relapse HIV-positive TB patients were offered immediate HIV program enrolment and ART within 8 weeks of anti-TB therapy (ATT) initiation. We used a quasi-experimental design, review of routine program data, and survival analysis and logistic regression methods to estimate study outcomes before (June 1, 2010-January 31, 2011) and after (August 1, 2011-March 31, 2012) our intervention among 473 patients with HIV-associated TB categorized into pre- (n = 248) and post-intervention (n = 225) cohorts.

RESULTS:

Patients in the pre- and post-intervention cohorts were mostly male (60.1% and 52.9%, respectively) and young (median age 33 years). In time-to-event analyses, a significantly higher proportion of patients in the post-intervention cohort linked to HIV care by 4 weeks post-ATT initiation (53.9% vs. 43.4%, p = 0.03), with median time to care linkage being 59 and 25 days in the pre- and post-intervention cohorts, respectively. In Cox proportional hazard modelling, patients receiving the integration intervention started ART by 8 weeks post-ATT at 1.33 times the rate (HR = 1.33, 95% CI 1.00-1.77) as patients pre-intervention. In logistic regression modelling, patients receiving the intervention were 2.02 times (95% CI 1.11-3.67) as likely to have a successful TB treatment outcome as patients not receiving the intervention.

CONCLUSIONS:

Integrating HIV treatment and care services into routine TB clinics using a one-stop shop model increased linkage to HIV care, rates of early ART initiation, and TB treatment success among patients with HIV-associated TB in Lusaka, Zambia.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Evaluación de Resultado en la Atención de Salud / Prestación Integrada de Atención de Salud / Fármacos Anti-VIH / Instituciones de Atención Ambulatoria / Antituberculosos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Año: 2018 Tipo del documento: Article País de afiliación: Zambia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / Evaluación de Resultado en la Atención de Salud / Prestación Integrada de Atención de Salud / Fármacos Anti-VIH / Instituciones de Atención Ambulatoria / Antituberculosos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: BMC Infect Dis Año: 2018 Tipo del documento: Article País de afiliación: Zambia